EPIS Releases New Version of AURORAxmp LAS VEGAS, April

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
36
EPIS Releases New Version of AURORAxmp

LAS VEGAS, April 25, 2017 (GLOBE NEWSWIRE) -- EPIS ( www.epis.com ),  the market leader in power market simulation, forecasting and analysis, announced the release of version 12.3 of its AURORAxmp software at the Platts Global Power Markets TM Conference . The latest version boasts a number of enhancements to storage logic, ancillary services, long-term logic, improved RPS modeling and nodal capabilities.

AURORAxmp 12.3 further solidifies its position as the most valuable power market forecasting and analysis software on the market today. It is fast, easy to use, and transparent. Upgrades in the new version include:

  • Enhanced Storage Logic —improved ability to model the intricacies of renewable and storage integration, electric vehicles, and other technologies. 
  • Ancillary Services Enhancements —significant enhancements, including sub-hourly dispatch and use in nodal studies, and improved MW reporting for simultaneous contributions to multiple products
  • Improved RPS Modeling —offers new option to identify resources not eligible to set capacity prices—especially useful when modeling RPS policies where renewable resources must be built but cannot participate in capacity markets. Also, RPS constraints can now be input as a percentage of demand or MWh value, giving more flexibility to specifying RPS targets over time.
  • Long-Term (LT) Capacity Expansion Logic Enhancements —now have the option to change dispatch-hour sampling dynamically—accelerating studies, but still providing detail on final production run.
  • New LT Constraint Types —including capacity and energy max limits, which provide more flexibility for build decisions to targets in LT studies.
  • New LT Reporting Option —new build report output table making it helpful to quickly see which constraints were binding (min, max by technology/fuel/area).
  • Nodal SCUC —version 12.3 also includes an exciting new option to run a full security constrained unit commitment (SCUC). The mixed-integer program that performs the commitment decisions now accounts for nodal constraints, including branch, corridor, and contingency constraints.  The new SCUC ability is in addition to a new, proprietary solving method that significantly speeds nodal analysis.

AURORAxmp v.12.3 is further enhanced by the proven and calibrated databases that either come with the license or as an add-on, including: U.S.-Canada, Europe or Mexico. The calibrated datasets simplify meaningful forecasting. All AURORAxmp databases include a base-case 25-year power price forecast and generator capacity expansion and retirement plan. The sources and procedures used to update the data are thoroughly documented. Updates to the databases are provided under the annual AURORAxmp license.

For the past 20 years, AURORAxmp has had a reputation for being best-in-class, with unmatched support. Version 12.3 further establishes its position as the leader in power market forecasting and analysis.

About EPIS EPIS, LLC ( www.epis.com ) is the developer of AURORAxmp , the leading-edge software for forecasting wholesale power market prices. The company also provides ready-to-use data for the United States-Canada, Europe, and Mexico.  The company delivers unrivaled customer support to its growing body of customers worldwide and, on average, adds a new enhancement to AURORAxmp, based on customer feedback and/or market changes, every week. A variety of organizations-including utilities (large and small), independent power producers (IPPs), developers, traders, energy consultants, regulatory agencies and universities-use AURORAxmp to model power system dispatch and the formation of both nodal and zonal wholesale power prices, and to perform a wide range of associated analytics over the short- and long-term. AURORAxmp is a comprehensive solution to power market modeling needs. Offices are located in Salt Lake City, UT, Tigard, OR and Sandpoint, ID.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading